0001209191-23-026796.txt : 20230502
0001209191-23-026796.hdr.sgml : 20230502
20230502210010
ACCESSION NUMBER: 0001209191-23-026796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TREACE JAMES T
CENTRAL INDEX KEY: 0001185191
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 23881365
MAIL ADDRESS:
STREET 1: 117 BRISTOL PLACE
CITY: PONTE VEDRA BEACH
STATE: FL
ZIP: 32082
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 471052611
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-28
0
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001185191
TREACE JAMES T
C/O TREACE MEDICAL CONCEPTS, INC.
100 PALMETTO PARK PLACE
PONTE VEDRA
FL
32081
1
0
0
0
0
Common Stock
2023-04-28
4
S
0
40000
25.0066
D
871441
D
Common Stock
2023-05-01
4
S
0
7640
25.037
D
863801
D
Common Stock
2023-05-01
4
S
0
2360
25.9103
D
861441
D
Common Stock
556183
I
By Spouse
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4100 to $25.3050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.5400 to $25.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5400 to $26.1500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Lisa Taylor as Attorney-in-fact for James T. Treace
2023-05-02